Before You Raise,
Launch, or Scale—
Know If You're Actually Ready
RŌG Health helps medical device leaders assess commercial readiness and make the next decision with confidence—before time, capital, and credibility are put at risk.
Medical device companies don't fail on technology.
They fail on sequencing.
Most innovations stall—or destroy value—not because the product doesn't work, but because critical decisions are made out of order.
- Launching before buyer clarity exists.
- Hiring sales before positioning and evidence are aligned.
- Fundraising with a story that doesn't match go-to-market reality.
- Chasing pilots or partnerships without repeatable commercial logic.
When the sequence is wrong, everything downstream becomes expensive.
Decision-grade clarity at critical commercial moments
RŌG Health partners with medical device leadership teams when the next move is expensive and difficult to reverse.
Through structured diagnostics and executive-level judgment, we help teams:
- Identify what's actually blocking progress.
- Surface hidden assumptions and misalignment.
- Understand what must happen first—and what must wait.
- Decide what to do now, next, later, or not at all.
The outcome is more than the deliverables.
It's confidence in the decision itself.
Three products.
One purpose: confident decisions.
Each examines the same company from a different vantage. Our work is structured, time-bound, and designed for high-stakes decisions.
Operator's Commercial Readiness Assessment (OCRA)
A self-authored workbook for medical device operators.
What it delivers:
- Thirty-eight questions across five commercial domains
- A formatted PDF of your complete responses
- A document organized by domain, ready to read, save, or share
Best for:
- Founders, CEOs, and commercial leaders at medical device companies
- Operators preparing for a higher-stakes conversation (raise, partnership, hire, board update)
- Anyone who wants the unrehearsed version of their own commercial thinking in writing
Commercial Launch & Impact Framework (CLIF)
A fast, external diagnostic designed to pressure-test assumptions and assess early commercial plausibility.
What it delivers:
- Clear articulation of how the company currently presents itself
- Market fit and buyer logic assessment
- Narrative, positioning, and differentiation critique
- Identification of visible gaps, risks, and open questions
Best for:
- Early commercialization thinking
- Resource-constrained teams
- Leaders seeking an independent outside view
Commercial Readiness
Diagnostic (CRD)
Our flagship diagnostic for companies at critical commercial inflection points.
What it delivers:
- Executive summary (board-ready)
- Commercial Readiness Scorecard
- Ranked top commercial blockers
- Forward-looking risk register
- 90-day decision roadmap
Best for:
- Pre-launch or early commercial medical device companies
- Teams preparing to scale, partner, or raise
- Situations where sequencing and alignment matter
After the diagnostic: Teams can execute the roadmap internally, with existing partners, or—when appropriate—with our support.
What clarity actually produces
When assumptions are pressure-tested and sequencing is made explicit, leadership gains a shared understanding of what matters—and what to do about it.
1
A clear articulation of what you're actually selling
What the company appears to do, who it's for, and why it matters—without internal translation or guesswork.
2
A pressure-tested view of market and buyer reality
Where the commercial story holds up, where it breaks, and where adoption friction is being underestimated.
3
A ranked view of the biggest blockers and risks
What is actually preventing progress—and what could derail it next if left unaddressed.
4
Clear guidance on what to do now—and what to wait on
Which actions create leverage immediately, which should be delayed, and which are distractions.
If the honest recommendation is to delay, re-sequence, or not proceed, we will say so.
Built for medical device teams
facing irreversible decisions
This is a fit if you are:
- A Class II / III medical device company (or similarly complex, regulated product)
- Pre-launch, early commercial, or experiencing stalled traction
- Preparing to make a major commitment (scale, hire, partner, raise)
- Willing to invest in decision-grade clarity before moving
This is often true (but not required): venture-backed, PE-backed, strategic division, or established private company.
This is not a fit if you are:
- Pre-concept or purely exploratory
- Looking for outsourced marketing execution as a starting point
- Unwilling to confront constraints or uncomfortable tradeoffs